18-545
Showing 1 - 25 of >10,000
Disease State of Oral Upadacitinib in Adolescent Participants
Recruiting
- Atopic Dermatitis
-
Ichinomiya-shi, Aichi, Japan
- +35 more
Jul 27, 2022
Wrist-Drop Trial in Lahore (Wrist Splint, Occupational Therapy)
Recruiting
- Wrist-Drop
- Wrist Splint
- Occupational Therapy
-
Lahore, Punjab, PakistanChaudary Muhammad Akram Teaching Hospital
May 24, 2023
Systemic Sclerosis, Scleroderma Trial in Worldwide (Anifrolumab (blinded), Placebo (blinded), Anifrolumab (unblinded, open
Not yet recruiting
- Systemic Sclerosis
- Scleroderma
- Anifrolumab (blinded)
- +2 more
-
Birmingham, Alabama
- +130 more
Jun 22, 2023
Active Psoriatic Arthritis Trial in Worldwide (TILD, matching injections)
Recruiting
- Active Psoriatic Arthritis
- TILD
- matching placebo injections
-
Anniston, Alabama
- +98 more
Nov 25, 2022
Nutritive Effects on Brain Myelination Trial in Chapel Hill (Control, Investigational)
Terminated
- Nutritive Effects on Brain Myelination
- Control
- Investigational
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Dec 13, 2021
Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (biological, other, drug)
Recruiting
- Pemphigus Vulgaris
- Pemphigus Foliaceus
- efgartigimod PH20 SC
- +2 more
-
Birmingham, Alabama
- +130 more
Dec 22, 2022
Ulcerative Colitis Trial in Worldwide (CP-690,500 5 mg, CP-690,550 10 mg)
Terminated
- Ulcerative Colitis
- CP-690,500 5 mg
- CP-690,550 10 mg
-
Mobile, Alabama
- +79 more
Aug 3, 2022
Schistosomiasis Trial in Seattle (Sm-p80, Sm-p80 + GLA-SE)
Recruiting
- Schistosomiasis
- Sm-p80
- Sm-p80 + GLA-SE
-
Seattle, WashingtonKaiser Permanente Washington Health Research Institute - Vaccine
Sep 21, 2022
Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (efgartigimod PH20 SC, prednisone)
Recruiting
- Pemphigus Vulgaris
- Pemphigus Foliaceus
- efgartigimod PH20 SC
- prednisone
-
Birmingham, Alabama
- +120 more
Dec 22, 2022
Monkeypox Virus Infection Trial in Boende (IMVAMUNE)
Active, not recruiting
- Monkeypox Virus Infection
- IMVAMUNE
-
Boende, Tshuapa, Congo, The Democratic Republic of theTshuapa site
May 11, 2022
ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory Trial (Tafasitamab)
Not yet recruiting
- ALL, Childhood B-Cell
- +2 more
- Tafasitamab
- (no location specified)
Nov 25, 2022
Assessing Adolescent Use of Nexplanon Over Time
Recruiting
- Contraception
- Contraceptive use (continuation/switching/discontinuation)
-
Salt Lake City, UtahUniversity of Utah
May 25, 2022
Melanoma, Lymphoma, Solid Tumor Trial in Worldwide (Pembrolizumab)
Recruiting
- Melanoma
- +4 more
- Pembrolizumab
-
Aurora, Colorado
- +18 more
Jan 5, 2023
Obsessions and Suicidality in Youth With Bipolar 1 Disorder
Completed
- Obsessions
- +3 more
- Psychometric assessment
-
Cairo, EgyptCairo University
May 18, 2023
Multiple Myeloma Trial in Worldwide (Elranatamab, Lenalidomide)
Recruiting
- Multiple Myeloma
-
Benowa, Queensland, Australia
- +132 more
Jan 24, 2023
Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Pomalidomide)
Recruiting
- Multiple Myeloma
- Elranatamab
- +3 more
-
Woolloongabba, Queensland, Australia
- +117 more
Aug 3, 2022
Apnea, Obstructive Sleep, Obstructive Sleep Apnea Trial in Hartford (OSA-18 Survey, Decisional Conflict (DCS))
Recruiting
- Apnea, Obstructive Sleep
- Obstructive Sleep Apnea
- OSA-18 Survey
- Decisional Conflict (DCS)
-
Hartford, ConnecticutConnecticut Children's Medical Center
Jun 20, 2023
Hypercholesterolemia, Hypercholesterolemia, Familial Trial in Cambridge (PCSK9 inhibitor, 68Ga-DOTATATE PET-MRI)
Not yet recruiting
- Hypercholesterolemia
- +3 more
- Inclisiran
- +2 more
-
Cambridge, United KingdomUniversity of Cambridge
Jan 13, 2023
Chronic Low-back Pain, Chronic Pain, Fibromyalgia Trial in Chapel Hill (Green Light stimulation, Equal Energy White stimulation,
Not yet recruiting
- Chronic Low-back Pain
- +2 more
- Green Light stimulation
- +2 more
-
Chapel Hill, North CarolinaUniversity Of North Carolina
Jul 13, 2023
Obesity Hypoventilation Syndrome on Exercise Capacity,
Not yet recruiting
- Obesity Hypoventilation Syndrome
- +4 more
- Assessment
-
Istanbul, TurkeyIstanbul University-Cerrahpasa
Nov 16, 2023
Lyme Borreliosis Trial in United States (VLA15, Placebo)
Active, not recruiting
- Lyme Borreliosis
- VLA15
- Placebo
-
Milford, Connecticut
- +4 more
Jul 6, 2021
Alzheimer Trial in Japan, United Kingdom, United States (LY3303560 - IV, Placebo - IV, Florbetapir F 18)
Completed
- Alzheimer Disease
- LY3303560 - IV
- +3 more
-
Melbourne, Florida
- +10 more
Jul 2, 2019
Eosinophilic Asthma Trial in Worldwide (Reslizumab, Placebo)
Lymphoma, Large B-Cell, Diffuse, Tumors by Histologic Type Trial in China (penpulimab, lenalidomide, Rituximab, Gemcitabine,
Not yet recruiting
- Lymphoma, Large B-Cell, Diffuse
- Neoplasms by Histologic Type
- penpulimab, lenalidomide, Rituximab, Gemcitabine, Oxaliplatin
-
Hefei, Anhui, China
- +3 more
Mar 3, 2022